402 related articles for article (PubMed ID: 10229626)
1. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors.
Cappelli A; Anzini M; Vomero S; Canullo L; Mennuni L; Makovec F; Doucet E; Hamon M; Menziani MC; De Benedetti PG; Bruni G; Romeo MR; Giorgi G; Donati A
J Med Chem; 1999 May; 42(9):1556-75. PubMed ID: 10229626
[TBL] [Abstract][Full Text] [Related]
2. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.
Cappelli A; Anzini M; Vomero S; Mennuni L; Makovec F; Doucet E; Hamon M; Bruni G; Romeo MR; Menziani MC; De Benedetti PG; Langer T
J Med Chem; 1998 Feb; 41(5):728-41. PubMed ID: 9513601
[TBL] [Abstract][Full Text] [Related]
3. Novel and highly potent 5-HT3 receptor agonists based on a pyrroloquinoxaline structure.
Campiani G; Cappelli A; Nacci V; Anzini M; Vomero S; Hamon M; Cagnotto A; Fracasso C; Uboldi C; Caccia S; Consolo S; Mennini T
J Med Chem; 1997 Oct; 40(22):3670-8. PubMed ID: 9357534
[TBL] [Abstract][Full Text] [Related]
4. Phenylimidazolidin-2-one derivatives as selective 5-HT3 receptor antagonists and refinement of the pharmacophore model for 5-HT3 receptor binding.
Heidempergher F; Pillan A; Pinciroli V; Vaghi F; Arrigoni C; Bolis G; Caccia C; Dho L; McArthur R; Varasi M
J Med Chem; 1997 Oct; 40(21):3369-80. PubMed ID: 9341912
[TBL] [Abstract][Full Text] [Related]
5. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D
J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407
[TBL] [Abstract][Full Text] [Related]
6. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and 5-HT3 receptor affinity of new quinolinecarboxylic acid derivatives.
Orjales A; Alonso-Cires L; López-Tudanca PL; Tapia I; Labeaga L; Mosquera R
Drug Des Discov; 2000; 16(4):271-9. PubMed ID: 10807033
[TBL] [Abstract][Full Text] [Related]
8. Benzoxazole derivatives as novel 5-HT3 receptor partial agonists in the gut.
Sato Y; Yamada M; Yoshida S; Soneda T; Ishikawa M; Nizato T; Suzuki K; Konno F
J Med Chem; 1998 Jul; 41(16):3015-21. PubMed ID: 9685241
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships for the binding of arylpiperazines and arylbiguanides at 5-HT3 serotonin receptors.
Dukat M; Abdel-Rahman AA; Ismaiel AM; Ingher S; Teitler M; Gyermek L; Glennon RA
J Med Chem; 1996 Sep; 39(20):4017-26. PubMed ID: 8831767
[TBL] [Abstract][Full Text] [Related]
10. Structure-affinity relationship studies on arylpiperazine derivatives related to quipazine as serotonin transporter ligands. Molecular basis of the selectivity SERT/5HT3 receptor.
Cappelli A; Giuliani G; Gallelli A; Valenti S; Anzini M; Mennuni L; Makovec F; Cupello A; Vomero S
Bioorg Med Chem; 2005 May; 13(10):3455-60. PubMed ID: 15848758
[TBL] [Abstract][Full Text] [Related]
11. Further studies on the interaction of the 5-hydroxytryptamine3 (5-HT3) receptor with arylpiperazine ligands. development of a new 5-HT3 receptor ligand showing potent acetylcholinesterase inhibitory properties.
Cappelli A; Gallelli A; Manini M; Anzini M; Mennuni L; Makovec F; Menziani MC; Alcaro S; Ortuso F; Vomero S
J Med Chem; 2005 May; 48(10):3564-75. PubMed ID: 15887964
[TBL] [Abstract][Full Text] [Related]
12. Discrimination in 5-HT(3) receptor binding in murine brain and cultured cell preparations.
Zhang ZJ; Trivedi BL; de Paulis T; Schmidt DE; Hewlett WA
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):123-32. PubMed ID: 11819030
[TBL] [Abstract][Full Text] [Related]
13. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Niso M; Perrone R; Tortorella V
J Med Chem; 2004 Dec; 47(26):6616-24. PubMed ID: 15588097
[TBL] [Abstract][Full Text] [Related]
14. Benzimidazole derivatives. Part 5: design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT1A/5-HT3 ligands.
López-Rodríguez ML; Benhamú B; Morcillo MJ; Tejada I; Avila D; Marco I; Schiapparelli L; Frechilla D; Del Río J
Bioorg Med Chem; 2004 Oct; 12(19):5181-91. PubMed ID: 15351401
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
[TBL] [Abstract][Full Text] [Related]
16. Modification of the structure of 4, 6-disubstituted 2-(4-alkyl-1-piperazinyl)pyridines: synthesis and their 5-HT2A receptor activity.
Paluchowska MH; Bojarski AJ; Bugno R; Charakchieva-Minol S; Wesołowska A
Arch Pharm (Weinheim); 2003 Apr; 336(2):104-10. PubMed ID: 12761763
[TBL] [Abstract][Full Text] [Related]
17. 5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines.
Kuipers W; Kruse CG; van Wijngaarden I; Standaar PJ; Tulp MT; Veldman N; Spek AL; IJzerman AP
J Med Chem; 1997 Jan; 40(3):300-12. PubMed ID: 9022796
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione.
Chloń G; Pawłowski M; Duszyńska B; Szaro A; Tatarczńska E; Kłodzińska AL; Chojnacka-Wójcik E
Pol J Pharmacol; 2001; 53(4):359-68. PubMed ID: 11990082
[TBL] [Abstract][Full Text] [Related]
19. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.
Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C; Kleven M
J Med Chem; 1999 May; 42(9):1648-60. PubMed ID: 10229633
[TBL] [Abstract][Full Text] [Related]
20. Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, and elymoclavine as partial agonists and antagonists at rat 5-HT2A receptors: pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high 5-HT2A receptor affinity.
Pertz HH; Milhahn H; Eich E
J Med Chem; 1999 Feb; 42(4):659-68. PubMed ID: 10052973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
